The Trump administration's "nonsensical tariffs" will sow long-term structural dislocation if implemented, Oppenheimer said in a note Monday.
"While we harbor strong views on unfolding chaos with tariff announcements, we will just say, 'You reap what you sow,'" the firm said.
The firm said GE HealthCare Technologies (GEHC), Varex Imaging (VREX), Integer (ITGR), and Intuitive Surgical (ISRG) were among the businesses most exposed to tariffs.
Intuitive Surgical specifically was at risk for "significant" contraction due to its exposure to both China and Mexico, the firm said.
"Our coverage universe is not immune," Oppenheimer said.
Oppenheimer said it preferred the "relative safety and diversification" of stocks like Abbott Laboratories (ABT) and Edwards Lifesciences (EW) in the current environment, though cautioned that both businesses faced foreign exchange rate risk.
According to the firm, small and mid cap firms with predominantly US exposure such as iRhythm Technologies (IRTC), TransMedics Group (TMDX), and AtriCure (ATRC) were better positioned in the current environment.
Price: 7.58, Change: -0.70, Percent Change: -8.45
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。